ArticleCPT: pharmacometrics & systems pharmacology2022

Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease.

Stefan Willmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.